Gilead Sciences Inc
Change company Symbol lookup
Select an option...
GILD Gilead Sciences Inc
SFDMY Shanghai Fudan Microelectronics Group Co Ltd
PTNR Partner Communications Company Ltd
CHPT ChargePoint Holdings Inc
BASMX iShares Total U.S. Stock Market Index Fund Investor A Shares
FLNT Fluent Inc
CCXI ChemoCentryx Inc
NVTA Invitae Corp
CLNE Clean Energy Fuels Corp
IMBBY Imperial Brands PLC
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Gilead Sciences, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of medicine to prevent and treat diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. The Company’s products for HIV/AIDS patients include Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. Its COVID-19 product is Veklury. The products for liver diseases includes Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. The products under hematology/oncology/cell therapy include Yescarta, Tecartus, Trodelvy, and Zydelig. The other products include Letairis (ambrisentan), Ranexa (ranolazine), Cayston, Jyseleca, and AmBisome (amphotericin B liposome for injection). The Company also sells and distributes generic versions of Epclusa and Harvoni in the United States. It sells and distributes its products in the United States through the wholesale channel. It operates in more than 35 countries worldwide.

Closing Price
$61.60
Day's Change
0.51 (0.83%)
Bid
--
Ask
--
B/A Size
--
Day's High
61.71
Day's Low
60.81
Volume
(Below Average)
Volume:
5,857,705

10-day average volume:
6,873,514
5,857,705

Upcoming Events

GILD's fiscal year ends in December
    • SEP
      14
      2022
    • Ex-dividend Date
    • Dividend amount
      $0.73
    • Record date
      September 15, 2022
    • Pay date
      September 29, 2022

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
August 2, 2022Q2 2022 Earnings Release$1.58$1.29 to $1.73$1.87
April 28, 2022Q1 2022 Earnings Release$2.12$1.38 to $2.17$2.08
February 1, 2022Q4 2021 Earnings Release$0.69$1.21 to $2.14$2.19
October 28, 2021Q3 2021 Earnings Release$2.65$1.47 to $2.16$2.11

Past Dividends

Ex-dividend dateAmountRecord datePay date
June 14, 2022$0.73June 15, 2022June 29, 2022
March 14, 2022$0.73March 15, 2022March 30, 2022
December 14, 2021$0.71December 15, 2021December 30, 2021
September 14, 2021$0.71September 15, 2021September 29, 2021

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.